The Biostatistics Resource is a joint effort between Roswell Park Cancer Institute and the Department of Biostatistics at the University at Buffalo. The objective of the Biostatistics Resource is to be strategically involved in the design, implementation, and analysis of scientific data generated by CCSG program members. This includes the articulation of study objectives, statement of hypotheses, the derivation of appropriate designs and models for the cost effective achievement of a study's objectives, the assurance that modern and appropriate statistical methods are used, monitoring interim and final analyses, and assisting in the writing of abstracts and manuscripts. The expertise provided by the staff ensures that the yield of useful information from the scientific studies conducted at Roswell Park Cancer Institute is maximized while the costs are minimized. With Alan Hutson, PhD, Chair of Biostatistics at both the University at Buffalo and Roswell Park Cancer Institute, Gregory Wilding, PhD, Assistant Chair, and several newly appointed PhD and MS level biostatisticians, the Resource has improved dramatically with respect to its technical expertise. This expertise spans biostatistics, molecular epidemiology, bioinformatics and statistical genetics. Most Resource projects require the use of standard and commercially available tools. More recently, with the explosion of high throughput technologies, particular problems require an innovative solution for which the Resource develops novel methodology and/or custom software. Within the Biostatistics Resource, the Biotechnical, Analytic and Visualization Resource (BAVR), headed by Daniel Gaile, PhD, has been developed to spearhead software development for complex statistical genetics and bioinformatics problems. The Resource's expanded and enhanced capabilities are made known to CCSG Program leaders through referrals, by the Scientific Review Committee's requirement that protocols and grant applications have input from a biostatistician, the mandate by funding agencies that proposals include statistical designs with proper power analyses, formal seminars given by Resource staff, and presentations at Program meetings. Strong synergies have also developed in terms of the relationship with the Statistics and Data Coordinating center for the Gynecologic Oncology Group (GOG). In addition, the Resource has been a fertile ground for training graduate students in biostatistics. The Resource is used by all six Programs. $251,993 in CCSG support is requested, representing 22% of the total operating budget.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Roswell Park Cancer Institute Corp
United States
Zip Code
Wintrob, Zachary A P; Hammel, Jeffrey P; Nimako, George K et al. (2017) Insulin use, hormone receptor status and hematopoietic cytokines? circulation in women with diabetes mellitus and breast cancer. Data Brief 11:382-390
Murphy, Maureen E; Liu, Song; Yao, Song et al. (2017) A functionally significant SNP in TP53 and breast cancer risk in African-American women. NPJ Breast Cancer 3:5
Liu, Song; Kumari, Sangeeta; Hu, Qiang et al. (2017) A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer. Elife 6:
Espinal, Allyson C; Buas, Matthew F; Wang, Dan et al. (2017) FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women? Breast Cancer Res Treat 166:559-568
Danaher, Patrick; Warren, Sarah; Dennis, Lucas et al. (2017) Gene expression markers of Tumor Infiltrating Leukocytes. J Immunother Cancer 5:18
Oakley, Emily; Bellnier, David A; Hutson, Alan et al. (2017) Surface markers for guiding cylindrical diffuser fiber insertion in interstitial photodynamic therapy of head and neck cancer. Lasers Surg Med 49:599-608
Gage-Bouchard, Elizabeth A (2017) Social support, flexible resources, and health care navigation. Soc Sci Med 190:111-118
Moore, Kathleen N; Tritchler, David; Kaufman, Kenneth M et al. (2017) Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol 147:396-401
Szender, J Brian; Papanicolau-Sengos, Antonios; Eng, Kevin H et al. (2017) NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer. Gynecol Oncol 145:420-425
Ho, Christine M; McCarthy, Philip L; Wallace, Paul K et al. (2017) Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT. Blood Adv 1:1056-1066

Showing the most recent 10 out of 1391 publications